Αποτελέσματα Αναζήτησης
17 Αυγ 2024 · Select appropriate treatment options for alpha-1 antitrypsin deficiency, such as augmentation therapy, bronchodilators, glucocorticoids, or liver transplantation, based on the patient's clinical status, disease progression, and response to previous interventions.
5 Ιαν 2024 · Alpha 1 antitrypsin deficiency (AATD) is a hereditary disorder first described in 1963 as a genetic cause of chronic obstructive pulmonary disease (COPD).1 AATD is characterized by low levels of alpha 1 antitrypsin (AAT) allowing neutrophil elastase (NE) to destroy the elastin structure of the lung.2 Although the major function of AAT as a ...
8 Απρ 2020 · Alpha1-antitrypsin (AAT) deficiency is one of the most common genetic diseases. Most persons carry two copies of the wild-type M allele of SERPINA1, which encodes AAT, and have normal...
20 Μαρ 2024 · Guidelines. Global strategy for diagnosis, management, and prevention of COPD; Diagnosis and treatment of lung disease associated with alpha one‐antitrypsin deficiency
Alpha‐1 antitrypsin deficiency is an inherited disorder that can cause chronic obstructive pulmonary disease (COPD). People who smoke are more seriously affected and have a greater risk of dying from the disease. Therefore, the primary treatment is to help people give up smoking.
This review summarizes the current research and outlooks regarding the obstacles to diagnosing and treating early alpha-1-antitrypsin deficiency (AATD). It draws on prior systematic reviews and expert surveys to discover precisely what difficulties ...
3 Μαρ 2015 · Alpha-1 antitrypsin deficiency (AATD), also known as alpha-1 proteinase inhibitor deficiency, is a genetic condition that leads to increased risk of lung and liver disease and several other conditions. The spectrum of AATD-related disease and the age at clinical onset is quite broad.
